Protein detail

SRC

Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)

Protein symbol
SRC
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
Protein classification
Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsTransporters
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)
Protein Class
Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsTransporters
Protein Function
  • Human disease related genes:Cardiovascular diseases:Hematologic diseases
  • Predicted intracellular proteins
  • ENZYME proteins:Transferases
  • Enzymes
  • Cancer-related genes:Candidate cancer biomarkers
  • Transporters:Accessory Factors Involved in Transport
  • Kinases:Tyr protein kinases
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
Entrez Gene Symbol
Gene Synonym
ASVc-srcSRC1
Gene Description
SRC proto-oncogene, non-receptor tyrosine kinase
Chromosome
20
Position
37344685-37406050
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Tissue SpecificliverBrain Regional SpecificmidbrainCell SpecificAdrenal cortex cellsSingle-Nuclei Brain SpecificBergmann glia
Function & Pathway
Protein Function
  • Human disease related genes:Cardiovascular diseases:Hematologic diseases
  • Predicted intracellular proteins
  • ENZYME proteins:Transferases
  • Enzymes
  • Cancer-related genes:Candidate cancer biomarkers
  • Transporters:Accessory Factors Involved in Transport
  • Kinases:Tyr protein kinases
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
KEGG
Reactome
Mediation Categories
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

128 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
SRCCHKAP35790Y530phosphorylationREACH_ProtMapperSparser_ProtMapperProtMapperProtMapper:22823952ProtMapper:15845350ProtMapper:28784162ProtMapper:26453921
SRCMATKP42679Y530phosphorylationREACH_ProtMapperSparser_ProtMapperProtMapperProtMapper:27600824ProtMapper:26453921
SRCPAG1Q9NWQ8Y530phosphorylationSparser_ProtMapperProtMapperProtMapper:21940449ProtMapper:27600824ProtMapper:28178691ProtMapper:7680927ProtMapper:21632985ProtMapper:22823952ProtMapper:23159740ProtMapper:18614016ProtMapper:10838156ProtMapper:28098256ProtMapper:19827767ProtMapper:22848394ProtMapper:28784162ProtMapper:16115959ProtMapper:19874824ProtMapper:15845350ProtMapper:20657842ProtMapper:26030592
SRCPTPREP23469Y530phosphorylationSIGNOR_ProtMapperProtMapperProtMapper:15522235
SRCPTPN21Q16825Y530phosphorylationSIGNOR_ProtMapperProtMapperProtMapper:15143158
SRCITGB3P05106Y530phosphorylationSparser_ProtMapperProtMapperProtMapper:16115959
SRCEGFRP00533Y419phosphorylationRLIMS-P_ProtMapperSparser_ProtMapperProtMapperProtMapper:22957061
SRCEGFRP00533Y216phosphorylationRLIMS-P_ProtMapperREACH_ProtMapperProtMapperProtMapper:14760089ProtMapper:16769082
SRCBSGP35613Y419phosphorylationRLIMS-P_ProtMapperProtMapperProtMapper:25428919
SRCIL25Q9H293Y419phosphorylationRLIMS-P_ProtMapperProtMapperProtMapper:27462789
Page 10 of 13PreviousNext

Ligand-Receptor Signaling

13 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorOmniPathNoYesNoNoNo
intracellularintracellularLOCATENoNoNoNoNo
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularUniProt_locationNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo
cell_adhesioncell_adhesionCellinkerYesYesNoNoNo
adhesionadhesionOmniPathYesYesNoNoNo
cell_adhesioncell_adhesionOmniPathYesYesNoNoNo
plasma_membraneplasma_membraneUniProt_locationNoNoNoNoNo
Page 1 of 2Next

Regulatory Interaction Network

362 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
SRCP12931CASP8Q14790YesNoYesSparser_ProtMapperPhosphoSite_MIMPMIMPPhosphoSite_norefSIGNORiPTMnetProtMapperRLIMS-P_ProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSite_ProtMapperProtMapper:16619028ProtMapper:19383910ProtMapper:30501030ProtMapper:27195913ProtMapper:27109099ProtMapper:24100030SIGNOR:16619028ProtMapper:27432652ProtMapper:31286874ProtMapper:19470771ProtMapper:29393970ProtMapper:34367939
SRCP12931SPD2AQ5TCZ1YesYesNoSparser_ProtMapperPhosphoPointSIGNORProtMapperHPRDRLIMS-P_ProtMapperREACH_ProtMapperProtMapper:24174371HPRD:9687503SIGNOR:20943948ProtMapper:19596797ProtMapper:31999741
SRCP12931FERM2Q96AC1YesYesNoSparser_ProtMapperPhosphoSite_norefSIGNORiPTMnetProtMapperRLIMS-P_ProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSite_ProtMapperSIGNOR:26037143ProtMapper:30248333ProtMapper:26037143ProtMapper:32104508
FERM2Q96AC1SRCP12931YesYesNoSIGNORSIGNOR:26037143
CHK1O14757SRCP12931YesYesNoSparser_ProtMapperSIGNORProtMapperREACH_ProtMapperPhosphoSitePhosphoSite_ProtMapperProtMapper:29954829PhosphoSite:29954829SIGNOR:29954829
SRCP12931EMDP50402YesNoYesSparser_ProtMapperphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPPhosphoSite_norefSIGNORiPTMnetProtMapperSIGNOR_ProtMapperREACH_ProtMapperPhosphoSitePhosphoSite_ProtMapperPhosphoSite:19789182ProtMapper:32290470SIGNOR:19789182ProtMapper:25008017ProtMapper:29684168ProtMapper:24609268ProtMapper:24365856ProtMapper:19789182ProtMapper:31693005PhosphoSite:29684168
SRCP12931MUC1P15941YesYesNoHPRD_MIMPSIGNORProtMapperHINTPhosphoSite_KEAphosphoELM_KEALi2012HPRDIntActPhosphoSite_ProtMapperBEL-Large-Corpus_ProtMapperphosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetPhosphoPointKEABioGRIDphosphoELMSIGNOR_ProtMapperPhosphoSiteKEA:11483589HPRD:11152665KEA:14521915ProtMapper:15212693HPRD:11483589HINT:11152665PhosphoSite:11152665HINT:21798038BioGRID:21798038KEA:11152665ProtMapper:11152665SIGNOR:11152665HINT:11483589phosphoELM:11152665IntAct:11152665IntAct:21798038IntAct:11483589
SRCP12931SC6A4P31645YesYesNoPhosphoSite_norefSIGNORProtMapperREACH_ProtMapperPhosphoSitePhosphoSite_ProtMapperSIGNOR:21992875PhosphoSite:21992875ProtMapper:31916747
SRCP12931DAG1Q14118YesYesYesHPRD_MIMPSIGNORProtMapperRLIMS-P_ProtMapperHINTPhosphoSite_KEAphosphoELM_KEALit-BM-17DOMINOHPRDWangphosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetPhosphoPointKEAHPRD_KEAphosphoELMSIGNOR_ProtMapperSPIKE_LCHPRD-phosLit-BM-17:17474147HINT:11724572DOMINO:17474147ProtMapper:18982058phosphoELM:12795607ProtMapper:12795607SPIKE_LC:17474147Lit-BM-17:11724572SIGNOR:12795607KEA:12795607HPRD:12795607HPRD-phos:12795607
SRCP12931CAV2P51636YesYesYesHPRD_MIMPSIGNORProtMapperdbPTMPhosphoSite_KEAphosphoELM_KEAHPRDCui2007CancerCellMapWangPhosphoSite_ProtMapperBEL-Large-Corpus_ProtMapperphosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetPhosphoPointKEAHPRD_KEAphosphoELMSIGNOR_ProtMapperPhosphoSiteSparser_ProtMapperNetPathHPRD-phosPhosphoSite:12091389dbPTM:15504032HPRD-phos:18669648HPRD-phos:12091389PhosphoSite:22819829ProtMapper:15212693KEA:15504032PhosphoSite:18081315dbPTM:12091389SIGNOR:12091389HPRD-phos:20068231CancerCellMap:15504032KEA:12091389ProtMapper:23826261dbPTM:17081983PhosphoSite:15504032phosphoELM:12091389ProtMapper:12091389HPRD:12091389NetPath:15504032ProtMapper:20068231PhosphoSite:20455999ProtMapper:18669648ProtMapper:15504032SIGNOR:15504032
Page 24 of 37PreviousNext

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyMass spectrometryWestern blottingFlow cytometry3315085003279541440091455
Sequence, Structure & Domains

Sequences

Length
536
Mass
59,835
Sequence
MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; Synonyms=c-src; IsoId=P12931-1; Sequence=Displayed; Name=2; Synonyms=c-srcN1, N1-Src; IsoId=P12931-2; Sequence=VSP_012134; Name=3; Synonyms=c-srcN2, N2-Src; IsoId=P12931-3; Sequence=VSP_061494
Alternative Sequence
117; T -> TRKVDVR (in isoform 2); 117; T -> TRKVDVSQTWFTFRWLQR (in isoform 3)

3D Structural Models

Turn
127..129; 196..198; 290..292; 302..304; 423..426; 460..462; 521..523
Helix
137..139; 146..148; 158..165; 226..233; 267..269; 307..319; 349..353; 355..358; 363..382; 392..394; 399..401; 410..413; 417..420; 429..431; 434..439; 444..459; 471..479; 492..501; 506..508; 512..520
Beta Strand
87..93; 99..102; 110..114; 118..126; 132..136; 140..142; 152..154; 167..170; 174..179; 181..183; 187..195; 199..209; 211..213; 215..218; 221..225; 240..242; 256..259; 270..278; 280..282; 283..289; 293..299; 328..332; 334..336; 338..341; 345..348; 395..397; 403..405
3D Structure
NMR spectroscopy (2); X-ray crystallography (74)

Domain & Motif Annotations

Compositional Bias
7..19; Basic and acidic residues
Domain (CC)
The SH2 and SH3 domains are important for the intramolecular and intermolecular interactions that regulate catalytic activity, localization, and substrate recruitment.
Domain (FT)
84..145; SH3; 151..248; SH2; 270..523; Protein kinase
Region
1..53; Disordered
Protein Families
  • Protein kinase superfamily
  • Tyr protein kinase family
  • SRC subfamily
Sequence Similarities
Belongs to the protein kinase superfamily. Tyr protein kinase family. SRC subfamily.
Clinical Relevance
Disease Involvement
Cancer-related genesDisease variantFDA approved drug targetsProto-oncogene
Biomarker
Phase 2; Phase 1; Approved; Phase 1/2; Phase 3; Investigative; Terminated
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000010810ENSG00000039068ENSG00000050820ENSG00000072201ENSG00000080824ENSG00000101266ENSG00000105401ENSG00000105976ENSG00000110395ENSG00000121774ENSG00000128052ENSG00000132670ENSG00000136932ENSG00000137486ENSG00000141480ENSG00000141736ENSG00000143537ENSG00000145675ENSG00000146648ENSG00000153317ENSG00000169398ENSG00000170248ENSG00000174775ENSG00000185499ENSG00000196396ENSG00000241794ENSG00000254087ENSG00000261371ENSG00000269335
Interaction Count
29
Interaction Dataset
intact_biogrid